CXCL10 and systemic sclerosis: Interestingly, when they compared CXCL10 to CCL2 (chemoattractant related to Th2 activation) levels at baseline vs. follow-up, they found that CXCL10 levels were more prominent in early SSc while CCL2 became dominant later.